Halbert Hargrove Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Halbert Hargrove Global Advisors's VRTX Position: Q2 2026 in Review
Halbert Hargrove Global Advisors opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 2 shares worth $964. The stake represents ﹤0.01% of the portfolio and ranks #447 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in VRTX as recently as Q3 2025.
Halbert Hargrove Global Advisors first reported a position in VRTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $5.09K in Q3 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Halbert Hargrove Global Advisors held 2 shares of Vertex Pharmaceuticals worth $964 as of Q2 2026.
- Vertex Pharmaceuticals was a new Halbert Hargrove Global Advisors position in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #447 holding.
- Halbert Hargrove Global Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
- Halbert Hargrove Global Advisors's Vertex Pharmaceuticals position peaked at $5.09K in Q3 2025.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.